The RANKL Inhibitor Denosumab Reduces Progression of the Total Sharp Score and Bone Erosions in Patients with Rheumatoid Arthritis

Article Information

DOI 
http://dx.doi.org/10.1177/155989770700700410
Published By 
SAGE Publications
Print ISSN 
1559-8977
Online ISSN 
2155-756X
Copyright & Usage 
© 2007 MD Conference Express

Author Information

  1. Maria Vinall
  1. Désirée van der Heijde, MD
    1. Leiden University Medical Center, Leiden, The Netherlands
View Full Text

Article usage

AbstractFullPDF
Apr 2015500
May 2015400
Jul 2015011
Aug 2015100
Oct 2015432
Nov 2015133
Total1576

Note: Article usage statistics are calculated and reported monthly.

Cited By...

  • No citing articles found.
Back to top

Tools

View Full Page PDF
Citation Tools
Email
The RANKL Inhibitor Denosumab Reduces Progression of the Total Sharp Score and Bone Erosions in Patients with Rheumatoid Arthritis
Permalink: Copy
Linkedin Share Button del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo StumbleUpon logo

Table of contents

Cited By...

  • No citing articles found.